Orange Grove Bio (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$126,000,000
Company Info
Founders
Marc Appel
Market
Healthcare & Wellness
Coinvestors
Lilly Ventures,Cincinnati Children's Hospital Medical Center,Great American Insurance Company,AlleyCorp
Company Description

A preclinical drug investment and development platform focused on driving down the cost of drug discovery while advancing therapies into clinical trials. Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement